259 related articles for article (PubMed ID: 16105039)
1. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
[TBL] [Abstract][Full Text] [Related]
2. Effects of adrenomedullin on the glomerular adrenomedullin system in a rat model of anti-thy1 glomerulonephritis.
Geissler B; Plank C; Hartner A; Amann K; Struwe FG; Hilgers KF; Rascher W; Dötsch J
Nephron Exp Nephrol; 2010; 115(3):e80-8. PubMed ID: 20431304
[TBL] [Abstract][Full Text] [Related]
3. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
5. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
9. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
10. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
11. Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis.
Dimmler A; Haas CS; Cho S; Hattler M; Forster C; Peters H; Schöcklmann HO; Amann K
Diagn Mol Pathol; 2003 Jun; 12(2):108-17. PubMed ID: 12766616
[TBL] [Abstract][Full Text] [Related]
12. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis.
Matsumoto M; Fujimoto S; Iwatsubo S; Sato Y; Hara S; Kitamura K; Eto T
Clin Exp Nephrol; 2004 Dec; 8(4):316-21. PubMed ID: 15619030
[TBL] [Abstract][Full Text] [Related]
16. The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis.
Monkawa T; Pippin J; Yo Y; Kopp JB; Alpers CE; Shankland SJ
Nephron Exp Nephrol; 2006; 102(1):e8-18. PubMed ID: 16179805
[TBL] [Abstract][Full Text] [Related]
17. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
Canaan-Kühl S; Ostendorf T; Zander K; Koch KM; Floege J
Kidney Int; 1998 May; 53(5):1143-51. PubMed ID: 9573528
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antisense monocyte chemoattractant protein-1 (MCP-1) in a rat model of mesangial proliferative glomerulonephritis.
Liu H; Zhang XP; Yi ZW
Ren Fail; 2013; 35(10):1418-28. PubMed ID: 23991758
[TBL] [Abstract][Full Text] [Related]
19. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
[TBL] [Abstract][Full Text] [Related]
20. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
